Purpose: Amyloid-β (Aβ) is a 36- to 43-amino-acid peptide that is a constituent of drusen, and it has been demonstrated to upregulate vascular endothelial growth factor (VEGF) expression by retinal pigment epithelial (RPE) cells. This study aimed to determine whether 4-phenylbutyl phosphonylacetate (PBA), a known endoplasmic reticulum (ER) stress inhibitor, can reduce Aβ-induced expression of VEGF in RPE cells. Methods: Aβ was added to the medium of regularly cultured or polarized ARPE-19 cells, a human RPE cell line, with or without PBA. The levels of VEGF and ER stress markers, namely GRP78/Bip, cleaved caspases 4 and 12 and GADD153/C-EBP homologous protein, were determined by enzyme-linked immunoassay, immunocytochemistry and Western blotting. Results: Exposure of ARPE-19 cells to Aβ induced GRP78/Bip expression and activated caspases 4 and 12; however, their expression was decreased by simultaneous exposure to PBA. Aβ increased the expression of VEGF both in regularly cultured and polarized ARPE-19 cells, but it was suppressed by PBA. PBA did not cause RPE cell apoptosis. Conclusion: Aβ has been suggested to be involved in the development of age-related macular degeneration; therefore, our findings suggest that drugs that target ER stress should be considered for the treatment of age-related macular degeneration.

Keywords:
Age-related macular degeneration, 4-phenylbutyl phosphonylacetate, Vascular endothelial growth factor, Amyloid-β, Endoplasmic reticulum stress
1.
Bressler SB, Maguire MG, Bressler NM, Fine SL: Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990;108:1442-1447.
2.
Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV: Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 2004;78:243-256.
3.
Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL: Amyloid-β is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 2003;9:184-190.
4.
Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH: The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 2002;99:11830-11835.
5.
Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I: The potential role of amyloid β in the pathogenesis of age-related macular degeneration. J Clin Invest 2005;115:2793.
6.
Schröder M, Kaufman RJ: The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-789.
7.
Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL: Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci 2002;43:2791-2798.
8.
Roybal CN, Yang S, Sun C-W, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF: Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 2004;279:14844-14852.
9.
Hoozemans J, Veerhuis R, Van Haastert E, Rozemuller J, Baas F, Eikelenboom P, Scheper W: The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 2005;110:165-172.
10.
Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M: Induction of neuronal death by ER stress in Alzheimer's disease. J Chem Neuroanat 2004;28:67-78.
11.
Ron D, Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529.
12.
Bian ZM, Elner SG, Elner VM: Regulated expression of caspase-12 gene in human retinal pigment epithelial cells suggests its immunomodulating role. Invest Ophthalmol Vis Sci 2008;49:5593-5601.
13.
Bian ZM, Elner SG, Elner VM: Dual involvement of caspase-4 in inflammatory and ER stress-induced apoptotic responses in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2009;50:6006-6014.
14.
Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J Cell Biol 2004;165:347-356.
15.
Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103.
16.
Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J: ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation 2009;6:41.
17.
Oyadomari S, Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381-389.
18.
Collins AF, Pearson H, Giardina P, McDonagh K, Brusilow S, Dover G: Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood 1995;85:43-49.
19.
Dover GJ, Brusilow S, Samid D: Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med 1992;327:569-570.
20.
Kubota K, Niinuma Y, Kaneko M, Okuma Y, Sugai M, Omura T, Uesugi M, Uehara T, Hosoi T, Nomura Y: Suppressive effects of 4- phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J Neurochem 2006;97:1259-1268.
21.
Maestri NE, Brusilow SW, Clissold DB, Bassett SS: Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 1996;335:855-860.
22.
Oh S, Hong HS, Hwang E, Sim HJ, Lee W, Shin SJ, Mook-Jung I: Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 2005;126:1292-1299.
23.
Özcan U, Yilmaz E, Özcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, Hotamisligil GS: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006;313:1137-1140.
24.
Qi X, Hosoi T, Okuma Y, Kaneko M, Nomura Y: Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Mol Pharmacol 2004;66:899-908.
25.
Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, Hinton DR: A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc 2009;4:662-673.
26.
Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM: Arpe-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996;62:155-169.
27.
Maminishkis A, Chen S, Jalickee S, Banzon T, Shi G, Wang FE, Ehalt T, Hammer JA, Miller SS: Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 2006;47:3612-3624.
28.
Kaneko H, Ye F, Ijima R, Kachi S, Kato S, Nagaya M, Higuchi A, Terasaki H: Histamine receptor H4 as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 2014;171:3754-3763.
29.
Ye F, Kaneko H, Nagasaka Y, Ijima R, Nakamura K, Nagaya M, Takayama K, Kajiyama H, Senga T, Tanaka H: Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration. Sci Rep 2015;5:7.
30.
Fujii Y, Kachi S, Ito A, Kawasumi T, Honda H, Terasaki H: Transfer of gene to human retinal pigment epithelial cells using magnetite cationic liposomes. Br J Ophthalmol 2010;94:1074-1077.
31.
Koyama Y, Matsuzaki S, Gomi F, Yamada K, Katayama T, Sato K, Kumada T, Fukuda A, Matsuda S, Tano Y: Induction of amyloid β accumulation by ER calcium disruption and resultant upregulation of angiogenic factors in ARPE19 cells. Invest Ophthalmol Vis Sci 2008;49:2376-2383.
32.
Doh SH, Kim JH, Lee KM, Park HY, Park CK: Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res 2010;1308:158-166.
33.
Li J, Wang JJ, Yu Q, Wang M, Zhang SX: Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett 2009;583:1521-1527.
34.
Gorbatyuk MS, Knox T, laVailmm, Gorbatyuk OS, Noorwez SM, Hauswirth WW, Lin JH, Muzyczka N, Lewin AS: Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc Natl Acad Sci 2010;107:5961-5966.
35.
Libby RT, Gould DB: Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. Adv Exp Med Biol 2010;664:403-409.
36.
Ijima R, Kaneko H, Ye F, Nagasaka Y, Takayama K, Kataoka K, Kachi S, Iwase T, Terasaki H: Interleukin-18 induces retinal pigment epithelium degeneration in mice. Invest Ophthalmol Vis Sci 2014;55:6673-6678.
37.
Lee KS, Lee HJ, Kim DH, Noh YH, Yu K, Jung HY, Lee SH, Lee JY, Youn YC, Jeong Y: Activation of perk signaling attenuates Aβ-mediated ER stress. PloS One 2010;5:e10489.
38.
Rao R, Ellerby H, Bredesen D: Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004;11:372-380.
39.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S: Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
40.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY: Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
41.
Ijima R, Kaneko H, Ye F, Takayama K, Nagasaka Y, Kataoka K, Funahashi Y, Iwase T, Kachi S, Kato S: Suppression of laser-induced choroidal neovascularization by the oral medicine targeting histamine receptor H4 in mice. Transl Vis Sci Technol 2015;4:6.
42.
Mullins RF, Russell SR, Anderson DH, Hagman GS: Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14:835-846.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.